My name is Dr. Ataya, and I am an associate professor of medicine in the University of Florida Division of Pulmonary, Critical Care & Sleep Medicine, director of the Pulmonary Hypertension Program and the HHT and Rare Lung Disease Program. I specialize in pulmonary disease, critical care medicine and internal medicine with clinical interest in pulmonary arterial hypertension (PAH), chronic thromboembolic pulmonary hypertension (CTEPH), hereditary hemorrhagic telangiectasia (HHT), lymphangioleiomyomatosis (LAM), pulmonary alveolar proteinosis (PAP) and other rare lung disorders.

My training started at the Royal College of Surgeons in Ireland (RCSI), where I earned my medical degree. I completed my internal medicine residency at the Cleveland Clinic in Ohio. Eventually, I completed my specialty training in pulmonary & critical care medicine here at UF in 2016. I am board certified by the American Board of Critical Care Medicine, American Board of Pulmonary Medicine and the American Board of Internal Medicine.

I maintain a membership of various medical professional societies, including the American Thoracic Society (ATS), America College of Chest Physicians (ACCP) and Pulmonary Hypertension Association (PHA). In addition, I am a strong patient advocate and am actively involved in various patient foundations.

I am involved in various clinical trials in the fields of pulmonary hypertension, intensive care medicine and rare pulmonary diseases.